Published On: Tue, Nov 10th, 2020
World | By

Medicago reports promising but preliminary results of possible COVID-19 vaccine

Medicago coronavirus vaccine trial

Canadian drug developer Medicago says a combination of its experimental COVID-19 vaccine and GlaxoSmithKline’s vaccine booster produced an antibody response in a Phase 1 clinical trial.

CBC | World News